Log in

NYSE:SYKStryker Stock Price, Forecast & News

$187.96
-1.34 (-0.71 %)
(As of 08/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$187.71
Now: $187.96
$192.96
50-Day Range
$173.76
MA: $187.12
$201.41
52-Week Range
$124.54
Now: $187.96
$226.30
Volume1.94 million shs
Average Volume1.95 million shs
Market Capitalization$70.45 billion
P/E Ratio44.65
Dividend Yield1.22%
Beta0.85
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Read More
Stryker logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.13 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.88 billion
Cash Flow$10.27 per share
Book Value$34.03 per share

Profitability

Net Income$2.08 billion

Miscellaneous

Employees40,000
Market Cap$70.45 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$187.96
-1.34 (-0.71 %)
(As of 08/5/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SYK shares have increased by 7.0% and is now trading at $187.96.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Stryker?

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 7 hold ratings, 16 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Stryker
.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Stryker
.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) issued its quarterly earnings results on Thursday, July, 30th. The medical technology company reported $0.64 EPS for the quarter, beating the Zacks' consensus estimate of $0.62 by $0.02. The medical technology company earned $2.76 billion during the quarter, compared to the consensus estimate of $2.63 billion. Stryker had a return on equity of 20.53% and a net margin of 11.38%.
View Stryker's earnings history
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Thursday, July 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.575 per share on Friday, October 30th. This represents a $2.30 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date is Tuesday, September 29th.
View Stryker's dividend history
.

What price target have analysts set for SYK?

26 equities research analysts have issued 1 year price targets for Stryker's stock. Their forecasts range from $150.00 to $248.00. On average, they expect Stryker's stock price to reach $217.39 in the next twelve months. This suggests a possible upside of 15.7% from the stock's current price.
View analysts' price targets for Stryker
.

Has Stryker been receiving favorable news coverage?

News articles about SYK stock have been trending somewhat negative on Thursday, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stryker earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days.
View the latest news about Stryker
.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Medtronic (MDT), Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), Abbott Laboratories (ABT), Visa (V), Alibaba Group (BABA), Bank of America (BAC) and NVIDIA (NVDA).

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by many different institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.45%), Swiss National Bank (0.42%), Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.35%), Fenimore Asset Management Inc. (0.15%), First Trust Advisors LP (0.15%) and Welch & Forbes LLC (0.14%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker.
View institutional ownership trends for Stryker
.

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Strs Ohio, Empire Life Investments Inc., CIBC Asset Management Inc, Railway Pension Investments Ltd, Jacobi Capital Management LLC, State of Michigan Retirement System, and Russell Investments Group Ltd.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell.
View insider buying and selling activity for Stryker
.

Which institutional investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including LA Financiere DE L Echiquier, Villere ST Denis J & Co. LLC, Envestnet Asset Management Inc., First Trust Advisors LP, Raymond James Financial Services Advisors Inc., Cadinha & Co. LLC, Royal London Asset Management Ltd., and WASHINGTON TRUST Co.
View insider buying and selling activity for Stryker
.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $187.96.

How big of a company is Stryker?

Stryker has a market capitalization of $70.45 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]

This page was last updated on 8/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.